Hepatitis C and autoreactivity

Digestive and Liver Disease

Volumn 39, Issue SUPPL. 1, 2007, Pages

  Bianchi, Francesco B ^a   Muratori, Paolo ^a   Granito, Alessandro ^a   Pappas, Georgios ^a   Ferri, Silvia ^a   Muratori, Luigi ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Autoantibodies; Autoimmune hepatitis; Hepatitis C

Indexed keywords

AMINOTRANSFERASE; ANTIVIRUS AGENT; AUTOANTIBODY; CD81 ANTIGEN; CRYOGLOBULIN; CYTOCHROME P450 2D6; GLYCOPROTEIN E2; HEPATITIS C ANTIBODY; HLA A1 ANTIGEN; HLA B8 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INTERFERON; LIVER KIDNEY MICROSOMAL ANTIBODY TYPE 1; POLYPROTEIN; SMOOTH MUSCLE ANTIBODY; STEROID; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; B LYMPHOCYTE ACTIVATION; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEPATITIS C; IMMUNOREACTIVITY; LIVER INJURY; LIVER NECROSIS; MOLECULAR MECHANICS; POLYCLONAL ACTIVATION; SEQUENCE HOMOLOGY; SEROLOGY; T LYMPHOCYTE; VIRUS CELL INTERACTION;

AUTOIMMUNE DISEASES; AUTOIMMUNITY; B-LYMPHOCYTES; HEPATITIS C, CHRONIC; HUMANS;

EID: 35148874137     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(07)80006-5     Document Type: Article

References (13)

1. Cassani F., Cataleta M., Valentini P., Muratori P., Giostra F., Francesconi R., et al. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology 26 (1997) 561-566
2. Lenzi M., Bellentani S., Saccoccio G., Muratori P., Masutti F., Muratori L., et al. Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort. Gut 45 (1999) 435-441
3. Muratori P., Muratori L., Stroffolini T., Pappas G., Terlizzi P., Ferrari R., et al. Prevalence of non-organ specific autoantibodies in HCV-infected subjects in the general population. Clin Exp Immunol 131 (2003) 118-121
4. Pileri P., Uematsu Y., Campagnoli S., Galli G., Falugi F., Petracca R., et al. Binding of hepatitis C virus to CD81. Science 282 (1998) 938-941
5. Bogdanos D., Lenzi M., Okamoto M., Rigopoulou E., Muratori P., Ma Y., et al. Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51. Int J Immunopathol Pharmacol 17 (2004) 83-92
6. Muratori L., Parola M., Ripalti A., Robino G., Muratori P., Bellomo G., et al. Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane. Gut 46 (2000) 553-561
7. Alvarez F., Berg P., Bianchi F., Bianchi L., Burroughs A., Cancado E., et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31 (1999) 929-938
8. Krawitt E. Autoimmune hepatitis. N Engl J Med 354 (2006) 54-66
9. Bottazzo G., Florin-Christensen A., Fairfax A., Swana G., Doniach D., and Groeschel-Stewart U. Classification of smooth muscle autoantibodies detected by immunofluorescence. J Clin Pathol 29 (1976) 403-410
10. Muratori P., Muratori L., Agostinelli D., Pappas G., Veronesi L., Granito A., et al. Smooth muscle antibodies and type 1 autoimmune hepatitis. Autoimmunity 35 (2002) 497-500
11. Muratori L., Lenzi M., Cataleta M., Giostra F., Cassani F., Ballardini G., et al. Interferon therapy in liver/kidney microsomal antibody type 1 positive patients with chronic hepatitis C. J Hepatol 21 (1994) 199-203
12. Garcia-Buey L., Garcia-Monzon C., Rodriguez S., Borque M., Garcia- Sanchez A., Iglesias R., et al. Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C. Gastroenterology 108 (1995) 1770-1777
13. Muratori L., Bogdanos D., Muratori P., Lenzi M., Granito A., Ma Y., et al. Susceptibility to thyroid disorders in hepatitis C. Clin Gastroenterol Hepatol 3 (2005) 595-603